Sugammadex Medichem 100 mg/ml šķīdums injekcijām Łotwa - łotewski - Zāļu valsts aģentūra

sugammadex medichem 100 mg/ml šķīdums injekcijām

medichem, s.a, spain - sugammadekss - Šķīdums injekcijām - 100 mg/ml

Sugammadex Mylan Unia Europejska - łotewski - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Unia Europejska - łotewski - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Unia Europejska - łotewski - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - rokuronija vai vekuronija izraisītas neiromuskulārās blokādes atsākšana. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Unia Europejska - łotewski - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neiromuskulārā blokāde - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq Unia Europejska - łotewski - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Kalceks 100 mg/ml šķīdums injekcijām Łotwa - łotewski - Zāļu valsts aģentūra

sugammadex kalceks 100 mg/ml šķīdums injekcijām

kalceks, a/s, latvia - sugammadekss - Šķīdums injekcijām - 100 mg/ml

Destele 150/30 mikrogrami tabletes Łotwa - łotewski - Zāļu valsts aģentūra

destele 150/30 mikrogrami tabletes

teva pharma b.v., netherlands - desogestrelum, ethinylestradiolum - tabletes - 150 µg/30 µg

Destele 150/20 mikrogrami tabletes Łotwa - łotewski - Zāļu valsts aģentūra

destele 150/20 mikrogrami tabletes

teva pharma b.v., netherlands - desogestrelum, ethinylestradiolum - tabletes - 150 µg/20 µg

Duphaston 10 mg apvalkotās tabletes Łotwa - łotewski - Zāļu valsts aģentūra

duphaston 10 mg apvalkotās tabletes

abbott healthcare products b.v., netherlands - didrogesterons - apvalkotās tabletes - 10 mg